Clinical Trial Title
A phase 3, randomized, double-blind, placebo-controlled, multicenter, evaluation of the safety of N1539 following major surgery.Contact Information
Clinical Trial Protocol Description:
The purpose of this study is to test a study drug for safety and pain management after an elective surgery.
Clinical Trial Eligibility Criteria:
In order to participate you must be having surgery which would require a 48 hour hospitalization and not be pregnant or breastfeeding.
You will be excluded from the study if any of the following criteria apply to you:
- Are HIV positive.
- Have cancer.
- Have a known bleeding disorder.
- Have a history of alcohol abuse.
This is a partial list of inclusion and exclusion criteria.
Study Details
Clinical Trial Investigator
Adam C. Young, MD
Contact Information
Sherry Robison
(312) 942-2985